| December 31 (millions of dollars) | 2007 | 2006 | |||||
| Balance sheet items in accordance with U.S. GAAP(8) | restated(9) | ||||||
| Current assets(3) | $ | 1,653 | $ | 1,265 | |||
| Investment and other assets(1)(7) | 150 | 102 | |||||
| Property, plant, and equipment (net)(1)(6) | 3,047 | 2,719 | |||||
| Current liabilities(2)(5) | (1,420 | ) | (1,178 | ) | |||
| Long-term debt(2) | (1,539 | ) | (1,584 | ) | |||
| Deferred income taxes(1)(2)(3)(4)(5)(6)(7) | (409 | ) | (394 | ) | |||
| Deferred credits and long-term liabilities(2)(4)(6)(7) | (495 | ) | (464 | ) | |||
| Common shareholders equity(5)(7) | $ | 987 | $ | 466 | |||
(1) Start-up Costs. Canadian GAAP provides
that when starting up a new facility or entity, expenditures incurred during
the pre-operating period may be deferred when certain criteria are met. Under
U.S. GAAP, all costs (except interest on constructed assets) associated with
start-up activities must be expensed as incurred. See Note 5 for information
on the Corporations start-up costs.
(2) Derivative Instruments and Hedging Activities. CICA
Section 3855 harmonizes Canadian and U.S. GAAP by establishing standards for
recognition and measurement of financial assets, liabilities and non-financial
derivatives. CICA Section 3865 harmonizes Canadian GAAP with U.S. GAAP SFAS No.
133 by establishing standards for when and how hedge accounting may be applied
and recorded. See Note 2 for further details. Certain differences that existed
before the implementation of the above standards on Jan. 1, 2007, pertaining to
the termination of interest rate swaps in 2002 continue to be reconciling items
between Canadian GAAP and U.S. GAAP. For information regarding the
Corporations use of derivatives and hedging activities under Canadian GAAP, see
Note 20.
(3) Inventory Costing. Canadian GAAP allows
fixed overhead costs associated with production activities to be expensed
during the period whereas U.S. GAAP requires an allocation of fixed and
variable production overhead to inventory.
(4) Stock-based compensation. Under Canadian
GAAP, the Employee Incentive Stock Option Plan is measured using a
fair-value-based method, while the Equity Appreciation Plan and the Restricted
Stock Unit Plan are classified as liability instruments and are marked-to-market
based on intrinsic value. U.S. GAAP, SFAS No. 123(R), Accounting for
Share-Based Payment, effective Jan. 1, 2006, requires the share-based
compensation transactions to be accounted for using a fair-value-based method,
such as the Black-Scholes method. The Company has adopted this standard using a
modified prospective application. The fair value of awards classified as
liability instruments must be remeasured at fair value subsequently at each
reporting date through the settlement date. Changes in fair value during the
requisite service period will be recognized as compensation cost over that
period. The cumulative effect for the periods prior to Dec. 31, 2005, of $5
million after-tax has been charged to reinvested earnings (deficit) at Jan. 1,
2006.
(5) Income Taxes. Beginning Jan. 1, 2007, FIN
48, Accounting for Uncertainty in Income Taxes, became effective for U.S. GAAP
reporting. FIN 48 clarifies the accounting for uncertainty in income taxes by
prescribing a minimum recognition threshold that a tax position is required to
meet before being recognized. An entity is required to recognize the best
estimate of a tax position if that position is more likely than not to be
sustained upon examination, based solely on the technical merits of the
position. NOVA Chemicals adopted the provisions of FIN 48 on Jan.
1, 2007, at which time a FIN 48 liability of $36 million was recognized by
reclassifying $34 million out of deferred tax liability and $4 million from the
current tax liability. This resulted in a $6 million increase in the liability
for unrecognized tax benefits and was accounted for as a reduction to the Jan.
1, 2007, U.S. GAAP balance in reinvested earnings. During 2007, these
differences have reversed and resulted in a $6 million decrease in tax expense
for U.S. GAAP purposes. Also, it is NOVA Chemicals policy to recognize
interest and penalties accrued related to unrecognized tax benefits in income
tax expense. At Dec. 31, 2007, NOVA Chemicals had approximately $4 million
accrued for the payment of interest and penalties.
(6) Restructuring. Due to differences in the
cost basis, under U.S. GAAP, of certain assets for which an impairment charge
has been recorded (see Note 13), the resulting charge is lower under U.S. GAAP.
(7) Pension Liability Adjustment. In 2006, for
U.S. GAAP reporting, SFAS No. 158, Employers Accounting for Defined Benefit
Pension and Other Postretirement Plans-an amendment of FASB Statements No. 87,
88, 106, and 132(R) was effective. SFAS No. 158 requires an employer to
recognize the overfunded or underfunded status of a defined benefit
postretirement plan (other than a multiemployer plan) as an asset or liability
in its statement of financial position and to recognize changes in that funded
status in the year in which the changes occur through accumulated other
comprehensive income. Accordingly, at Dec. 31, 2006, the Corporation has
recognized an additional pension and post-retirement liability of $124 million,
resulting in a charge of $82 million (net of tax) to accumulated other comprehensive
income. In 2006 (prior to adoption of SFAS No. 158) and 2005, SFAS No. 87,
Employers Accounting for Pensions, was followed with respect to pension
accounting, which required an employer to record an additional minimum
liability (AML) if the unfunded accumulated benefit obligation exceeded the
accrued pension liability or if there was a prepaid pension asset with respect
to the plan. If an AML was recognized, an intangible asset, in an amount not
exceeding the unrecognized prior service cost, was also recognized. The excess
of the AML, over the intangible asset, if any, was charged to other
comprehensive income, net of income tax effects. At Dec. 31, 2007, NOVA
Chemicals increased its SFAS No. 158 pension and post-retirement liability by
$66 million, resulting in a charge of $45 million (net of tax) to accumulated
other comprehensive income.
(8) Joint Ventures. NOVA Chemicals accounts for
its interests in joint ventures using the proportionate consolidation method
under Canadian GAAP. As permitted by specific United States Securities and
Exchange Commission exemptions, adjustments to reflect equity accounting, as
required under U.S. GAAP, have not been made. The equity method would not
result in any changes in NOVA Chemicals net income (loss) or shareholders
equity; however, all assets, liabilities, revenue, expenses, and most cash flow
items would decrease when compared with the amounts that are presented using
proportionate consolidation.
(9) Certain costs that were previously included as inventoriable costs
were removed in 2007. Prior periods have been restated.













